Shortcut to Body Shortcut to main menu

News & Event

  • Home
  • News
  • News & Event
Pharmbio Korea to have a new production plant in N. Chungcheong Prov.

According to Yonhap News,

The city of Chungju signed a KRW 15.5 billion investment contract with Pharmbio Korea Inc., bio-pharmaceuticals maker, on Jul 10.

Pharmbio vowed to make greater contribution to investment and local job creation with its counterpart, who also pledged administrative support whenever necessary at the MOU signing ceremony.

The pharmaceutical company unleashed a plan to build a new factory on a 3,234㎡ site near vacant space inside the local industry cluster by the end of January in 2022.
The investor, founded in 1999, has been producing medicines applied in urology, gastroenterology, general surgery, OB-GYN, while expanding business scope into dietary supplements and derma-cosmetics as well.

Head of Pharmbio said “Putting public health above profits, we’ll make the investment lead to healthier and better communities.”

Source Text

Copyrights Yonhap News. All Rights Reserved.
Reprint or redistribution without permission is prohibited.

Source: Yonhap News (Jul 10 , 2020)

** This article was translated from Korean.